SPOTLIGHT -
Top 5 Takeaways From the Real Psychiatry Conference
Check out some of the top clinical pearls gleaned from presenters at Real Psychiatry.
Examples of Quality of Life Improvement for Patients With Tardive Dyskinesia
Check out 2 high-level examples of patient quality of life improvement following treatment for tardive dyskinesia.
Designing an Effective Treatment Strategy for Tardive Dyskinesia
What are the signs of increased struggle with tardive dyskinesia? Here's what Erin Crown, MHS, PA-C, Psych-CAQ, picks up on during patient visits.
Teasing Out Tardive Dyskinesia
Tardive dyskinesia can be difficult to discern...
Managing Medication Side Effects: What to Share With Your Patients
Here's how to address medication side effects with patients.
COVID-19: The Advent of Virtual Psychiatry
COVID-19 increased the usage of telemedicine drastically, but is that always a good thing?
Factors When Choosing an ADHD Treatment
What 5 factors should you look at when selecting ADHD treatment?
Research on Pause: COVID-19's Impact on Drug Development
Let's explore COVID-19's impact on psychiatric research...
Gauging ADHD Treatment Success: Improvement in Quality of Life
Let's define success for patients with ADHD...
The Importance of "Mattering" in the Wake of the Pandemic
"Who are you important to? If you passed tomorrow, who would show up at your funeral?"
Whole Person Care: Choosing an ADHD Treatment
When a patient has comorbidities like anxiety, substance use, and depression, how can you best select a treatment?
An Incredible Evolution: Celebrating Our 40th Anniversary With Our Editor in Chief
Come celebrate the evolution of Psychiatric Times and psychiatry as a whole!
Optimize, Augment, or Switch: Best Practices for Prescribing ADHD Medication
When prescribing ADHD medications, when is the best time to switch treatments?
The Keys to Successful Collaboration Amongst the Entire Health Care Team
How can we improve patient outcomes? Collaboration.
Considering Comorbid Symptoms When Addressing ADHD
Ancillary symptoms may be key in guiding treatment management for ADHD.
How to Implement a Strategy for Treating Tardive Dyskinesia
Here are 4 things to do when implementing a treatment strategy for tardive dyskinesia.
Addressing Comorbid Bipolar Disorder and ADHD
Comorbid bipolar disorder and ADHD: a big problem.
Challenges in Treating Tardive Dyskinesia: How to Have Productive Conversations With Patients
Here's how to have productive conversations with patients with tardive dyskinesia in order to improve outcomes.
Recovery as the Goal: Challenges in Schizophrenia Treatment
How can we get back to recovery as the treatment goal for schizophrenia?
Schizophrenia in 2025: The Dawn of a New Era?
2024 into 2025: a period of highs and lows for schizophrenia treatment.
Partnering With the Psych NP Network
We're excited to preview our new upcoming partnership with the Psych NP Network at Real Psychiatry!
The Evolution of Bipolar Disorder Over the Past 40 Years
How has bipolar treatment changed over the past 40 years? The celebration of 40 years of Psychiatric Times continues at the Real Psychiatry conference.
Postpartum Depression: Top Tips to Provide Optimized Care
Check out these top tips for treating postpartum depression from the Real Psychiatry conference!
The Most Common Challenges in Treating Bipolar Disorder
The top 3 issues in treating bipolar disorder are...
Breaking Down Barriers to Quality Care for Patients With Schizophrenia
Digital therapeutics may help improve negative symptoms associated with schizophrenia.
40 Years of Change in Psychiatry
We've upgraded our phones and computers... is it time to upgrade our psychiatric medications?
Relating Science to Patients in Innovative Ways: Welcome to the First Day of Real Psychiatry
Carmen Kosicek, MSN, PMHNP-BC, is ready to teach nurse practitioners and advanced providers in a fun, innovative way at Real Psychiatry in Scottsdale, AZ.
Don't Miss Us at Real Psychiatry!
Are you attending Real Psychiatry this weekend?
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder
DLX-001 is a novel neuroplastogen under development for the treatment of major depressive disorder. Learn more about the latest phase 1 data here.
Therapeutic Advances in Alzheimer Disease
Do lifestyle interventions really work in Alzheimer disease and what are the underlying mechanisms? Learn more in this ACNP 2024 Annual Meeting session!
